Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06854601Phase 3Completed
Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12
Anxiety Disorders and SymptomsAttention Deficit Hyperactivity Disorder (ADHD)
PrincipalinvestigatorStart date: 2019-07-13

Research Network

Collaboration Network

14 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

State Budgetary Healthcare Institution "Orenburg Regional Clinical Psychiatric Hospital №1"

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yuliya O. Boychevskaya, MD

State Budgetary Healthcare Institution "Specialized Clinical Psychiatric Hospital №1" of the Ministry of Health of the Krasnodar Territory

Related
1 trials

Shared therapeutic areas:

Anxiety Disorders and SymptomsAttention Deficit Disorder with Hyperactivity

Worked with same sponsors:

Pharmasoft
Collaborated on 1 trial
Similarity Score24%

Anna N. Platonova, Cand.Med.Sci, MD

State Budgetary Healthcare Institution of the City of Moscow "Scientific and Practical Center for Child Psychoneurology of the Moscow Department of Healthcare"

Related
1 trials

Shared therapeutic areas:

Anxiety Disorders and SymptomsAttention Deficit Disorder with Hyperactivity

Worked with same sponsors:

Pharmasoft
Collaborated on 1 trial
Similarity Score24%

Polina S. Nikiforova, MD

State Autonomous Healthcare Institution of the Sverdlovsk Region "Multispecialty Clinical Medical Center 'Bonum'

Related
1 trials

Shared therapeutic areas:

Anxiety Disorders and SymptomsAttention Deficit Disorder with Hyperactivity

Worked with same sponsors:

Pharmasoft
Collaborated on 1 trial
Similarity Score24%

Dina D. Gainetdinova, Dr.Med.Sci, Prof.

Federal State Budgetary Educational Institution of Higher Education "Kazan State Medical University" Ministry of Health of the Russian Federation

Related
1 trials

Shared therapeutic areas:

Anxiety Disorders and SymptomsAttention Deficit Disorder with Hyperactivity

Worked with same sponsors:

Pharmasoft
Collaborated on 1 trial
Similarity Score24%

Anna S. Nezabudkina, MD

Limited Liability Company "Medical Technologies"

Related
1 trials

Shared therapeutic areas:

Anxiety Disorders and SymptomsAttention Deficit Disorder with Hyperactivity

Worked with same sponsors:

Pharmasoft
Collaborated on 1 trial
Similarity Score24%

Elmira S. Sagutdinova, Cand.Med.Sci, MD

Limited Liability Company "European Medical Center 'UGMK-Health'"

Related
1 trials

Shared therapeutic areas:

Anxiety Disorders and SymptomsAttention Deficit Disorder with Hyperactivity

Worked with same sponsors:

Pharmasoft
Collaborated on 1 trial
Similarity Score24%

Elena V. Levitina, Dr.Med.Sci, Prof.

Federal State Budgetary Educational Institution of Higher Education "Tyumen State Medical University" Ministry of Health of the Russian Federation,

Related
1 trials

Shared therapeutic areas:

Anxiety Disorders and SymptomsAttention Deficit Disorder with Hyperactivity

Worked with same sponsors:

Pharmasoft
Collaborated on 1 trial
Similarity Score24%

Irina N. Vakula, MD

Limited Liability Company "Center for Professional Therapy"

Related
1 trials

Shared therapeutic areas:

Anxiety Disorders and SymptomsAttention Deficit Disorder with Hyperactivity

Worked with same sponsors:

Pharmasoft
Collaborated on 1 trial
Similarity Score24%

Natalya E. Maksimova, Cand.Med.Sci, MD

Federal State Budgetary Educational Institution of Higher Education "Tver State Medical University" Ministry of Health of the Russian Federation

Related
1 trials

Shared therapeutic areas:

Anxiety Disorders and SymptomsAttention Deficit Disorder with Hyperactivity

Worked with same sponsors:

Pharmasoft
Collaborated on 1 trial
Similarity Score24%

Olga S. Panina, Cand.Med.Sci, MD

Limited Liability Company "DNA Research Center"

Related
1 trials

Shared therapeutic areas:

Anxiety Disorders and SymptomsAttention Deficit Disorder with Hyperactivity

Worked with same sponsors:

Pharmasoft
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06854601Phase 3PrincipalInvestigator

Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12

Anxiety Disorders and SymptomsAttention Deficit Hyperactivity Disorder (ADHD)
Completed

All 1 trials loaded